| Literature DB >> 34335567 |
Kavita Rawat1, Aruna Pal2, Samiddha Banerjee3, Abantika Pal4, Subhas Chandra Mandal5, Subhasis Batabyal1.
Abstract
CD14 (also known as the monocyte differentiation antigen) is an important immune response gene known to be primarily responsible for innate immunity against bacterial pathogens, and as a pattern recognition receptor (PRR), binds with LPS (endotoxin), lipoproteins, and lipotechoic acid of bacteria. So far very limited work has been conducted in parasitic immunology. In the current study, we reported the role of CD14 in parasitic immunology in livestock species (sheep) for the first time. Ovine CD14 is characterized as a horse-shoe shaped bent solenoid with a hydrophobic amino-terminal pocket for CD14 along with domains. High mutation frequency was observed, out of total 41 mutations identified, 23 mutations were observed to be thermodynamically unstable and 11 mutations were deleterious in nature, causing major functional alteration of important domains of CD14, an indication of variations in individual susceptibility for sheep against Haemonchus contortus infestations. In silico studies with molecular docking reveal a role of immune response against Haemonchus contortus in sheep, which is later confirmed with experimental evidence through differential mRNA expression analysis for sheep, which revealed better expression of CD14 in Haemonchus contortus infected sheep compared to that of non-infected sheep. We confirmed the above findings with supportive evidence through haematological and biochemical analyses. Phylogenetic analysis was conducted to assess the evolutionary relationship with respect to humans and it was observed that sheep may well be used as model organisms due to better genetic closeness compared to that of mice.Entities:
Keywords: CD14 molecule; Haemonchus contortus; differential mRNA expression analysis; in silico analysis; molecular docking; molecular phylogeny; sheep
Year: 2021 PMID: 34335567 PMCID: PMC8324245 DOI: 10.3389/fimmu.2021.664877
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Amplification of 1122bp fragment of CD14 gene of sheep and goat. Lane 1-2: Amplified product from cDNA of CD14 gene of sheep Lane M: 100bp DNA ladder plus.
Figure 2Alignment of ruminant CD14 derived peptide with other species. (A) Alignment through MSA viewer. (B) CLUSTAL format alignment by MAFFT. 1: Sheep (Ovis aries), 2: CB cattle (Bos taurus x Bos indicus), 3: Buffalo (Bubalus bubalis), 4: Goat (Capra hircus), 5: Human (Homo sapiens), 6: Mice (Mus musculus), 7: Dog (Canis lupus familiaris), 8: Cat (Felis catus), 9: Horse (Equus caballus). Green line, Signal peptide; Blue line, LPS binding site; Yellow line, LPS signaling site; Red line, Leucine zipper; Black overline, Leucine rich repeat; Red line, Leucine zipper; Pink line, Domain linker prediction site. * means consensus for single amino acid and it is conserved across the species. ** means two successive amino acids for CD14 correspond to consensus sequence and these amino acid are conserved across the species. Similarly *** corresponds to three amino acids. **** corresponds to four amino acids and so on.
Amino acid variations in different species of ruminants.
| Sl no. | Amino acid position | Buffalo | Cattle | Sheep | Goat | Remarks/Domain present | Analysis by I-mutant | Analysis by Provean |
|---|---|---|---|---|---|---|---|---|
| 1 | 13 | P | P | P |
| Site for signal peptide | Large decrease of stability | |
| 2 | 14 | P |
| P |
| Large decrease of stability | ||
| 3 | 22 | T | T | T |
| Large decrease of stability | ||
| 4 | 23 | T | T | T |
| |||
| 5 | 30 | D | D | D |
| Domains for LPS binding site 1, LPS signaling site, site for LRR | Deleterious | |
| 6 | 31 | D | D | D |
| |||
| 7 | 32 | D | D | D |
| |||
| 8 | 74 |
|
| V |
| Large decrease of stability in A | ||
| 9 | 77 |
|
|
|
| LPS binding site | Large decrease of stability N, | |
| 10 | 131 |
| T | T | T | LRR site | ||
| 11 | 143 |
| L | L | L | LRR site | Large decrease of stability | |
| 12 | 173 |
|
|
|
| |||
| 13 | 179 | A |
| A | A | |||
| 14 | 186 | C |
| C | C | Site for di-sulphide bond | Large decrease of stability | Deleterious |
| 15 | 193 | E |
| E | E | Large decrease of stability | ||
| 16 | 195 | L |
| L | L | Large decrease of stability | Deleterious | |
| 17 | 201 | S |
| S | S | Deleterious | ||
| 18 | 210 | G |
| G | G | Deleterious | ||
| 19 | 212 | M |
| M | M | Large decrease of stability | ||
| 20 | 221 | P | P | P |
| Large decrease of stability | Deleterious | |
| 21 | 223 | L | L | L |
| Large decrease of stability | Deleterious | |
| 22 | 236 |
| P | P |
| Large decrease of stability | ||
| 23 | 238 | G | G | G |
| |||
| 24 | 239 | V | V | V |
| Large decrease of stability | Deleterious | |
| 25 | 248 | V |
| V | V | decrease of stability | ||
| 26 | 252 | S | S | S |
| |||
| 27 | 263 | A |
| A | A | Site for LRR | Large decrease of stability | |
| 28 | 267 | A |
| A | A | Large decrease of stability | ||
| 29 | 276 |
|
|
|
| Large decrease of stability | ||
| 30 | 281 | L | L | L |
| Domain linker, leucine zipper | Large decrease of stability | Deleterious |
| 31 | 318 | E | E | E |
| Domain | ||
| 32 | 321 |
|
|
|
| Linker | Large decrease of stability | |
| 33 | 336 | Q | Q |
| Q | Large decrease of stability | ||
| 34 | 337 |
| H | H | H | |||
| 35 | 345 | G | G | G |
| LRR | Deleterious | |
| 36 | 349 | A | A | A |
| LRR | Large decrease of stability | |
| 37 | 350 | C | C | C |
| |||
| 38 | 353 | S |
| S |
| Deleterious | ||
| 39 | 356 | T | T | T |
| |||
| 40 | 364 | A | A | A |
| |||
| 41 | 366 | L | L | L |
| Large decrease of stability |
Letters representing different amino acids in the bold indicates the variation from the consensus sequence.
Bioinformatics analysis of CD14 derived peptide for domestic ruminants.
|
| cross of | Ovis aries |
| |
|---|---|---|---|---|
| Gene Bank Protein id | ABE68724 | ADB92696.1 | ASZ84508.1 | ABE68725.1 |
| GC content of gene | 62.3 | 62.7 | 62.92 | 62.21%. |
| leucine rich repeats | Six | Nine | Three | Seven |
| leucine content, | 17.2% | 16.89% | 16.89% | 15.5% |
| putative N-linked glycosylation sites, | 4 | 4 | 4 | 3 |
| sites for O-linked glycosylation |
| 5 sites for O- linked glycosylation at amino acid positions 128, 131, 134, 145, 147, | 6 sites | 5 O-linked glycosylation sites. amino acid positions 128, 131, 139, 144 and 145 |
| Thr 13,17,19,21 | ||||
| 131, 237, | ||||
| disulphide bridges |
| Four | Four | Four |
| amino acid positions 26-37, 39-52, 186-216, 240-270 | ||||
| LPS binding site | 4 sites, | four LPS binding sites were depicted from 29th -32nd, 44th-47th, 55th-59th and 77th -83th amino acid positions | four LPS binding sites were depicted from 29th -32nd, 44th-47th, 55th-59th and 77th -83th amino acid positions | Four LPS binding site from 29th -32nd, 44th-47th, 55th-59th and 77th -83th amino acid positions |
| 29th -32nd, 44th-47th, 55th-59th and 77th -83th amino acid positions | ||||
| LPS signaling sites | Three LPS signalling sites were predicted for amino acid positions as 27th -33th,109-119th, 169-171th | Three LPS signalling sites were predicted for amino acid positions as 27th -33th,109-119th, 169-171th amino acid | Three LPS signalling sites were predicted for amino acid positions as 27th -33th,109-119th, 169-171th amino acid | three LPS signaling sites |
| Three LPS signalling sites were predicted for amino acid positions as 27th -33th,109-119th, 169-171th | ||||
| regions of alpha helix |
| five regions were detected for alpha helix conformation as 4-12, 67-73, 241-244, 343-346, 360-368 | five regions of alpha helix amino acid positions 4-18, 46-52, 81-84, 241-244 and 361-370 | |
| regions of beta strand | 11 regions for beta strands were predicted from amino acid positions 119-121, 145-147, 173-175, 181-182, 197-199, 225-227, 252-254, 278-280, 299-301, 321-323 and 345-347 in bubaline CD14 molecule | eleven regions were identified for beta strand conformation as 60-61, 118-122, 145-147, 173-176, 181-182, 197-199, 225-227, 252-254, 278-280, 299-301, 321-324 amino acid positions | twelve regions of beta sheet were predicted | |
| amino acid positions 26-27, 34-37, 59-60, 118-122, 145-147, 173-176, 181-182, 197-199, 225-228, 252-254, 299-301, 321-323 | ||||
| , leucine rich nuclear export signal | 7 | 7 sites at amino acid positions 12, 15, 16, 17, 117, 122,127 | 7 sites at amino acid positions 12, 15, 16, 17, 117, 122,127 | seven amino acid positions. acid positions 15, 16, 17, 20, 117, 122, and 127 of goat CD14 peptide |
| leucine zipper | amino acid position 279th to 300th in bubaline CD14 gene | amino acid position 279 of CB CD14 peptide | amino acid position 279 of CB CD14 peptide | Leucine zipper pattern was found at amino acid position 279 |
| domain linker, | Domain linker site was predicted for amino acid positions 121-146 and 283-334 | for amino acid positions 121-146 and 283-334 | for amino acid positions 121-146 and 283-334 | Domain linker site was predicted for amino acid positions 121-150 and 283-334. |
| site for a glycosyl phosphatidyl inositol anchor located at C-terminus | glycosyl phosphatidyl inositol (GPI) anchor located at C-terminus near 353th position of the CD14 molecule | glycosyl phosphatidyl inositol (GPI) anchor located at C-terminus near 345th position of the CD14 molecule | glycosyl phosphatidyl inositol (GPI) anchor located at C-terminus near 353th | glycosyl phosphatidyl inositol (GPI) anchor located at C-terminus near 344th position of the CD14 molecule |
| Molecular weight | 39705.07 Daltons | 39939.29 Daltons | 39645.00 | 39929.42 Da |
Writings in bold indicates the variation in a particular species with respect to other species under comparison.
Figure 4TM alignment of 3D structure of sheep with other ruminants. (A) TM alignment of the 3D structure of sheep and goat CD14 molecules. Green, Sheep CD14 molecule, Cyan, Goat CD14 molecule. (B) TM alignment of the 3D structure of sheep and cattle CD14 molecules. Green, Sheep CD14 molecule, Orange, Cattle CD14 molecule. (C) TM alignment of the 3D structure of sheep and buffalo CD14 molecules; Green, Sheep CD14 molecule; Pink, Buffalo CD14 molecule.
Figure 33D structure of sheep CD14. (A) 3D structure of ovine CD14 gene-Swiss prot view. (B) 3D structure of ovine CD14 gene-Pymol view (with LPS binding sites). (C) 3D structure of ovine CD14 gene-Surface view (with LPS binding sites). (D) Sheep CD14- groove (pathogen binding site).
Figure 5Depiction of receptor binding site for CD14. (A) Pocket or groove (LPS binding site) for TM aligned CD14 sheep and CD14 buffalo. (B) Pocket or groove (LPS binding site) for TM aligned CD14 sheep and CD14 goat.
Figure 9Differential mRNA expression profiling of ovine CD14 with respect to non-infected and infected (Haemonchus infected).
Figure 6String network-Molecular interaction of ovine CD14 molecule with other related molecules.
Figure 7KEGG analysis depicting biochemical pathway involved in CD14 molecules.
Figure 8Phylogenetic analysis of mammals and birds with respect to CD14 gene.
Mean FEC of the Non-infected and Infected sheep with Haemoncus contortus.
| Health Status of the sheep | Mean Faecal Egg Count |
|---|---|
| Non-infected | 50 ± 5.56a |
| Disease | 550 ± 9.45b |
Superscript a and b represent significant differences at P ≤ 0.05.
Figure 10Binding of ovine CD14 with alpha tubulin and beta tubulin of Haemonchus contortus. (A) Alignment of 3D structure of ovine CD14 molecule (green) with alpha tubulin (brown) of Haemonchus contortus. (B) Line drawing of binding site of CD14 molecule with alpha tubulin (brown) of Haemonchus contortus. (C) Alignment of 3D structure of ovine CD14 molecule (green) with beta tubulin (purple) of Haemonchus contortus. (D) Line drawing of binding site of CD14 molecule (green) with beta tubulin (purple) of Haemonchus contortus.
Haematological parameters in disease and non-infected sheep.
| S.no | Parameter | Disease | Non-infected |
|---|---|---|---|
| 1 | Hb gm/dl | 7.96b ± 0.19 | 10.37a ± 0.19 |
| 2 | ESR mm | 1.00 ± 0.00 | 0.90 ± 0.04 |
| 3 | PCV% | 27.84b ± 0.67 | 36.25a ± 0.64 |
| 4 | TEC/cumm (106) | 3.98b ± 0.05 | 4.95a ± 0.08 |
| 5 | TLC/cumm | 9200.00a ± 159.23 | 6587.50b ± 210.81 |
| 5 | Neutrophil % | 53.50a ± 1.00 | 30.25b ± 0.59 |
| 6 | Eosonophil% | 16. 62a ± 0.49 | 2.12b ± 0.44 |
| 7 | Basophil% | 0.00 | 0.00 |
| 8 | Lymphocyte% | 29.12b ± 0.29 | 60.87a ± 0.29 |
| 9 | Monocyte% | 1.37 ± 0.18 | 1.87 ± 0.29 |
The Mean values that have superscript, was showing significant difference between groups. The superscript ‘a’ was showing high mean value than ‘b’. Significant at (p ≤ 0.05).
Biochemical parameters (liver function test) in disease and non-infected sheep.
| Sr. no | Parameters | Disease | Non-infected |
|---|---|---|---|
| 1 | Total protein (g/dl) | 6.11b ± 0.02 | 7.77a ± 0.03 |
| 2 | Albumin (g/dl) | 1.92b ± 0.04 | 2.80a ± 0.03 |
| 3 | Globulin(g/dl) | 4.18a ± 0.06 | 4.97b ± 0.06 |
| 4 | Albumin : Globulin | 0.46b ± 0.01 | 0.58a ± 0.01 |
| 5 | S.G.P.T IU/L | 39.75a ± 1.4 | 32.12b ± 1.0 |
| 6 | S.G.O.T IU/L | 86.87a ± 2.6 | 68.87b ± 2.7 |
| 7 | Alkaline Phosphatase IU/L | 85.25a ± 3.89 | 64.87b ± 2.09 |
| 8 | Total Bilirubin mg/dl | 0.67a ± 0.07 | 0.37b ± 0.03 |
| 9 | Direct Bilirubin mg/dl | 0.30a ± 0.02 | 0.16b ± 0.01 |
| 10 | Indirect Bilirubin mg/dl | 0.37a ± 0.09014 | 0.21b ± 0.05 |
The Mean values that have superscript, was showing significant difference between groups. The superscript ‘a’ was showing high mean value than ‘b’. Significant at (p ≤ 0.05).
Biochemical parameters (kidney function test) in disease and non-infected sheep.
| S.No. | Parameters | Non-infected | Infected |
|---|---|---|---|
| 1 | Glucose mg/dl | 55.50b ± 1.21 | 68.62a ± 2.33 |
| 2 | Creatinine mg/dl | 1.71a ± 0.05 | 1.20b ± 0.02 |
| 3 | Uric acid mg/dl | 0.89a ± 0.01 | 0.76b ± 0.04311 |
| 4 | Urea mg/dl | 48.37a ± 1.2 | 36.12b ± 1.56 |
| 5 | BUN mg/dl | 23.62a ± 0.73 | 16.87b ± 0.95 |
| 1 | Glucose mg/dl | 55.50b ± 1.21 | 68.62a ± 2.33 |
| 2 | Creatinine mg/dl | 1.71a ± 0.05 | 1.20b ± 0.02 |
The Mean values that have superscript, was showing significant difference between groups. The superscript ‘a’ was showing high mean value than ‘b’. Significant at (p ≤ 0.05).